Skip to main content
Medicines for Malaria Venture
Developing antimalarials to save lives
Main navigation
Our work
Go back
Our work
Antimalarials to save lives
Go back
Antimalarials to save lives
Annual report 2022
Antimalarials for children
Antimalarials for pregnant women
Antimalarial drug resistance
History of antimalarial drugs
Global health and societal change
Go back
Global health and societal change
Gender equity
Climate change and malaria
Sustainable Development Goals
Research and development
Go back
Research and development
MMV's pipeline of antimalarial drugs
Target product & candidate profiles
Frontrunner templates
Rethinking chemoprevention
Access to medicines
Go back
Access to medicines
Product registration maps
African manufacturing
Antimalarial drug toolkits
Seasonal malaria chemoprevention
Partnering & opportunities
Go back
Partnering & opportunities
Partnership model
Go back
Partnership model
Global research networks
MMV partner map
Call for proposals
Newsroom
Malaria
Go back
Malaria
About malaria
Go back
About malaria
Lifecycle of the malaria parasite
Species of Plasmodium parasites
Malaria facts and statistics
Symptoms and treatments
Malaria prevention
Relapsing malaria
Severe malaria
Malaria guidelines
About us
Go back
About us
About us
Go back
About us
Careers
Events
FAQs
Diversity, Equity & Inclusion
Policies
Donors
People & governance
Go back
People & governance
Staff bios
Board of Directors
North America Inc. Board
Access and Product Management Advisory Committee
Expert Scientific Advisory Committee
Global Safety Board
MMVOpen
Go back
MMVOpen
Open compounds
Go back
Open compounds
Call for antimalarial compounds
Global health priority box
Pandemic Response Box
Open dose and PK prediction tool
Open source drug discovery programme
Go back
Open source drug discovery programme
Open data repository
MMVOpen team
What are you looking for?
Home
Antimalarial drug availability
Injectable Artesunate
Injectable Artesunate